BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36054235)

  • 1. Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.
    Sheldon JR; Himmel LE; Kunkle DE; Monteith AJ; Maloney KN; Skaar EP
    PLoS Pathog; 2022 Sep; 18(9):e1010809. PubMed ID: 36054235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baumannii can use multiple siderophores for iron acquisition, but only acinetobactin is required for virulence.
    Sheldon JR; Skaar EP
    PLoS Pathog; 2020 Oct; 16(10):e1008995. PubMed ID: 33075115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive Roles of Two Acinetobactin Isomers in Challenging Host Nutritional Immunity.
    Kim M; Kim DY; Song WY; Park SE; Harrison SA; Chazin WJ; Oh MH; Kim HJ
    mBio; 2021 Oct; 12(5):e0224821. PubMed ID: 34517755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia.
    Bachman MA; Lenio S; Schmidt L; Oyler JE; Weiser JN
    mBio; 2012 Nov; 3(6):. PubMed ID: 23169997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of iron-regulated membrane proteins identify FhuE receptor as a target to inhibit siderophore-mediated iron acquisition in Acinetobacter baumannii.
    Tiwari V; Rajeswari MR; Tiwari M
    Int J Biol Macromol; 2019 Mar; 125():1156-1167. PubMed ID: 30579900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.
    Hood MI; Mortensen BL; Moore JL; Zhang Y; Kehl-Fie TE; Sugitani N; Chazin WJ; Caprioli RM; Skaar EP
    PLoS Pathog; 2012; 8(12):e1003068. PubMed ID: 23236280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.
    Murray GL; Tsyganov K; Kostoulias XP; Bulach DM; Powell D; Creek DJ; Boyce JD; Paulsen IT; Peleg AY
    J Infect Dis; 2017 Feb; 215(suppl_1):S52-S57. PubMed ID: 28375520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin.
    Bachman MA; Miller VL; Weiser JN
    PLoS Pathog; 2009 Oct; 5(10):e1000622. PubMed ID: 19834550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity.
    Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipocalin2 as a potential antibacterial drug against Acinetobacter baumannii infection.
    Lim D; Park SJ; Kim HY; Shin M; Song M
    J Microbiol; 2022 Apr; 60(4):444-449. PubMed ID: 35344190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
    Song JY; Cheong HJ; Choi WS; Heo JY; Noh JY; Kim WJ
    J Med Microbiol; 2011 May; 60(Pt 5):605-611. PubMed ID: 21233298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Acinetobacter baumannii Znu System Overcomes Host-Imposed Nutrient Zinc Limitation.
    Hesse LE; Lonergan ZR; Beavers WN; Skaar EP
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548324
    [No Abstract]   [Full Text] [Related]  

  • 14. Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.
    Wilson BR; Bogdan AR; Miyazawa M; Hashimoto K; Tsuji Y
    Trends Mol Med; 2016 Dec; 22(12):1077-1090. PubMed ID: 27825668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering the virulence factors, regulation, and immune response to
    Shadan A; Pathak A; Ma Y; Pathania R; Singh RP
    Front Cell Infect Microbiol; 2023; 13():1053968. PubMed ID: 36968113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin 2 Protects Against
    Wang Q; Li S; Tang X; Liang L; Wang F; Du H
    Front Immunol; 2019; 10():2594. PubMed ID: 31781104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence Potential and Treatment Options of Multidrug-Resistant (MDR)
    Kumar S; Anwer R; Azzi A
    Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683425
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
    Jeon J; Park JH; Yong D
    BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Acinetobacter baumannii, Zinc-Regulated Peptidase Maintains Cell Wall Integrity during Immune-Mediated Nutrient Sequestration.
    Lonergan ZR; Nairn BL; Wang J; Hsu YP; Hesse LE; Beavers WN; Chazin WJ; Trinidad JC; VanNieuwenhze MS; Giedroc DP; Skaar EP
    Cell Rep; 2019 Feb; 26(8):2009-2018.e6. PubMed ID: 30784584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.